KFDA reviews foreign GMP facilities

The Korea Food and Drug Administration has begun to review GMP facilities of Sandoz in India to ensure the generic quality of a lipid-lowering agent, a source said recently.

The administration launched a review group and conducted an on-the-spot inspection of Sandoz India.

So far, the KFDA has conducted its on-spot inspections on GMP facilities of Merck, Pfizer and Schwarz Pharma

“The ...